RecallGuide.ca
    Health productsUpdated Jan 3, 2026RAN-RanitidineOfficial source

    RAN-Ranitidine recall in Canada: impurity risk

    Share:

    In plain language

    This recall involves RAN-Ranitidine 150mg and 300mg tablets sold in Canada. It's being recalled because affected lots may contain an impurity called N-nitrosodimethylamine (NDMA). Stop using the product and follow the return steps in the official notice.

    What to do

    • Stop using the product immediately.
    • Check the lot numbers on your product.
    • Contact Sun Pharma Canada Inc. for instructions.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • RAN-Ranitidine 150mg

      Lot: 7703396A, 7703396B

    • RAN-Ranitidine 300mg

      Lot: 7703365A, 7702668A

    Why this matters

    Impurity risk

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: 7703365A, 7702668A, 7703396A, 7703396B

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Impurity risk

    What should consumers do?

    Stop using the product immediately. Check the lot numbers on your product. Contact Sun Pharma Canada Inc. for instructions.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Impurity risk

    When was this product recalled?

    This product was recalled on October 29, 2019.

    Is the RAN-Ranitidine brand affected by this recall?

    Yes, RAN-Ranitidine products are affected by this recall. This recall involves RAN-Ranitidine 150mg and 300mg tablets sold in Canada. It's being recalled because affected lots may contain an impurity called N-nitrosodimethylamine (NDMA). Stop using the product and follow the return steps in the official notice.